Navigation Links
ViroPharma to Present at Three September Healthcare Conferences
Date:8/28/2008

EXTON, Pa., Aug. 28 /PRNewswire-FirstCall/ -- ViroPharma Incorporated (Nasdaq: VPHM) today announced that Vincent Milano, president and chief executive officer of ViroPharma, will present at the Thomas Weisel Partners 2008 Healthcare Conference at 8:00 A.M. ET on Thursday, September 4, 2008. The conference is being held at the Four Seasons Hotel in Boston, MA.

ViroPharma also announced that William Roberts, vice president, corporate communications of ViroPharma will present at the 15th Annual BioCentury Newsmakers in the Biotech Industry Conference at 1:30 P.M. ET on Thursday, September 4, 2008. The conference is being held at the Millennium Broadway Hotel in New York.

Mr. Roberts also will present at the UBS Global Life Sciences Conference at 8:00 A.M. ET on Tuesday, September 23, 2008. The conference is being held at the Grand Hyatt in New York.

ViroPharma's presentations will be webcast live for investors through http://www.viropharma.com and available for a period of 14 days following the conferences.

About ViroPharma Incorporated

ViroPharma Incorporated is committed to the development and commercialization of products that address serious diseases treated by physician specialists and in hospital settings. ViroPharma commercializes Vancocin(R) approved for oral administration for treatment of antibiotic- associated pseudomembranous colitis caused by Clostridium difficile and enterocolitis caused by Staphylococcus aureus, including methicillin-resistant strains (for prescribing information, please download the package insert at http://www.viropharma.com/Products.aspx). ViroPharma c
'/>"/>

SOURCE ViroPharma Incorporated
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. ViroPharma to Present at Two Upcoming Healthcare Conferences
2. ViroPharma Provides 2008 Outlook
3. ViroPharma to Present at the BIO CEO & Investor Conference
4. ViroPharma to Release 2007 Fourth Quarter and Full Year Financial Results on February 27, 2008
5. ViroPharma to Present at the Susquehanna Financial Group Second Annual Significant Options in Healthcare Conference
6. ViroPharma to Present at the Cowen & Company 28th Annual Healthcare Conference
7. ViroPharma to Present at the Seventh Annual JMP Securities Research Conference
8. ViroPharma to Present at Two Upcoming Healthcare Conferences
9. Viropharma Comments On Upcoming FDA Advisory Committee Meeting
10. ViroPharma Provides Update on Upcoming FDA Advisory Committee Meeting to Discuss Bioequivalence of Locally Acting Gastrointestinal Drugs
11. ViroPharma To Acquire Lev Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... Arizona (PRWEB) January 15, 2014 2013 ... for Scottsdale’s Brain State Technologies®. They saw continued independent ... Medical Center who were awarded a $1 million grant ... published in “Brain and Behavior” a peer reviewed journal, ...
(Date:1/14/2014)... 14, 2014 Carahsoft and CDS Federal ... 23, 2014 at 2pm EST (11am PST), “Natural Language ... focuses on how technology can turn raw, heterogeneous data ... government agencies. The online webinar will last approximately one ...
(Date:1/14/2014)... 2014 The largest international professional organization of ... therapeutic derivatives thereof has endorsed an educational program ... the challenges of adulterated herb and botanical products. ... The Society for Medicinal Plant and Natural ...
(Date:1/14/2014)... 14, 2014 Global Record Systems, ... information technology solutions for patients, physicians, the biopharmaceutical ... announced today the signing of a three-year Research ... Drug Administration (FDA). This initiative is designed ...
Breaking Biology Technology:Dynamic Innovative Technology Showcased at Scottsdale Company’s Open House 2Dynamic Innovative Technology Showcased at Scottsdale Company’s Open House 3Webcast - Natural Language Processing: Converting Raw Data into Actionable Knowledge – Hosted by Carahsoft and CDS Federal Services 2World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 2World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 3World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 4World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 5World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 6World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 7World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 8Global Record Systems Announces Research Collaboration Agreement with FDA to Create a Novel “Big Data” Paradigm for Collection of Patient Safety and Outcomes Information 2
... What do Saturn and flowers have in common? , ... recognizable in the natural world. Now, at an extremely ... of Massachusetts have created a unique set of conditions ... consistently assemble themselves into these and other complex shapes. ...
... (Nasdaq: FOLD ) announced today that Stephen ... resigned from the Company,s Board of Directors effective February ... of Amicus, board since 2004. About Amicus Therapeutics ... novel, oral therapeutics known as pharmacological chaperones for the ...
... Directors wishes to confirm to Stockholders that at its meeting ... 15 with effect from February 17, 2009. This initiative ... interests of keeping stockholders and other stakeholders informed the Board ... release the company from its United States Securities and Exchange ...
Cached Biology Technology:Sophisticated nano-structures assembled with magnets 2Sophisticated nano-structures assembled with magnets 3EESTECH Inc - Release From SEC Filing 2EESTECH Inc - Release From SEC Filing 3EESTECH Inc - Release From SEC Filing 4
(Date:4/24/2014)... A new study from investigators with the Autism ... on identifying genes associated with risk for autism, has ... (CNV) genetic testing offers an important tool in individualized ... by Autism Speaks, the world,s leading autism science and ... 50 research centers in 11 countries. The report, published ...
(Date:4/24/2014)... bacteria attack plants, they often inject harmful proteins ... suppress natural defenses. However, in some plants, bacteria ... a potential host. Now, researchers at the University ... that allows the bacteriaknown mostly for attacking tomatoesto ... natural anti-infective treatments that work with food-producing plants ...
(Date:4/24/2014)... shows that cells are more resilient in taking care ... missing critical components, cells can adapt and make copies ... a study published in this week,s Cell Reports ... showed that cells can grow normally without a crucial ... information is stored in DNA, which has to be ...
Breaking Biology News(10 mins):Autism Genome Project delivers genetic discovery 2Autism Genome Project delivers genetic discovery 3Plants send out signals attracting harmful bacteria, MU study finds 2Cell resiliency surprises scientists 2
... to improve nutrition, indoor air pollution, immunization coverage and ... significantly reduce child mortality from pneumonia, according to a ... Public Health. Researchers found that these strategies combined could ... reduce pneumonia deaths by more than 90 percent. Pneumonia ...
... found at health food stores could be the key to ... cause diarrhea, tooth decay and, in some severe cases, death. ... of proteins in both bacterial cells and human cells called ... shows that interrupting the way selenoproteins are made can halt ...
... from the perspective of cell biology, Nietzsche may have been ... make us stronger. In a review article published in the ... ( http://www.fasebj.org ), scientists from the Mayo Clinic explain how ... shut down old, diseased, or otherwise unwanted cells (called "apoptosis") ...
Cached Biology News:Cost-effective measures could stop child pneumonia deaths 2Newly discovered reactions from an old drug may lead to new antibiotics 2Scientists explain how 'death receptors' designed to kill our cells may make them stronger 2
... SUPERaseIn RNase Inhibitor (patent pending) is a ... noncovalently binds and inhibits the most common ... C, 1 and T1. SUPERaseIn can be ... could be problematic. It is ideal for ...
... RNaseOUT Recombinant Ribonuclease Inhibitor ... of pancreatic-type ribonucleases such as ... inhibitors RNaseOUT Recombinant Ribonuclease Inhibitor ... a molecular weight ~52 kDa. ...
...
... Core Kit contains all the ... assays on a wide range ... to dNTPs, the Core Kit ... used BIOLASE DNA polymerase, which ...
Biology Products: